Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001943462-25-000001
Filing Date
2025-01-10
Accepted
2025-01-10 16:27:18
Documents
1
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3105
  Complete submission text file 0001943462-25-000001.txt   5105
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 203-632-6341
Dellora Investments LP (Reporting) CIK: 0001943462 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 25523356